share_log

Needham Reiterates Buy on Cormedix, Maintains $10 Price Target

Moomoo 24/7 ·  Apr 9 06:08

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment